- Market Capitalization, $K 621,297
- Shares Outstanding, K 97,382
- Annual Sales, $ 860 K
- Annual Income, $ -52,700 K
- 60-Month Beta 0.65
- Price/Sales 31.33
- Price/Cash Flow N/A
- Price/Book 5.99
|Period||Period Low||Period High||Performance|
| || |
-0.85 (-11.76%)since 08/17/21
| || |
-0.29 (-4.35%)since 06/17/21
| || |
+3.04 (+91.02%)since 09/17/20
SEONGNAM-SI, , /PRNewswire/ -- Summit Corporation, a Korean safety glove manufacturer, announced that Summit Corporation acquired EN certification for 3 of leather safety gloves and will accelerate overseas...
Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today reports its financial results and provides an update on its operational progress for the second quarter and six months ended...
Based on a thorough review of the design and enrollment status of two ongoing blinded Phase III Ri-CoDIFy trials, Summit Therapeutics Inc. (NASDAQ: SMMT) today announced that it will combine its two blinded...
/PRNewswire/ -- The Antimicrobials Working Group (AWG) announced today the addition of Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) (Acurx) to its coalition of companies with the mission to combat drug...
Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit" or the "Company") is today displaying three preeminent ePosters at the prestigious 31st European Congress of Clinical Microbiology & Infectious Diseases...
Summit Therapeutics Inc. (NASDAQ: SMMT) (the "Company") today announced that members of our scientific team will present breakthrough research updates at the 31 European Congress of Clinical Microbiology...
/PRNewswire/ -- The Antimicrobials Working Group (AWG) announced today the addition of Crestone, Inc. (Crestone) to its coalition of companies with the mission to combat drug resistant infections and...
Summit Therapeutics Inc. (NASDAQ: SMMT) is set to join the broad-market Russell 3000(R) Index at the conclusion of the 2021 Russell indexes annual reconstitution, effective after the US markets open on...
Summit Therapeutics Inc. (NASDAQ: SMMT) invites our shareholders and other interested parties to attend our Company's Annual Shareholders' Meeting, which will be held virtually on Wednesday, June 16, 2021,...
Summit Therapeutics PLC (SMMT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price...
|Summit Therapeu ADR|
|Invesco Nasdaq Biotechnology ETF|
|Oppenheimer Russell 2000 Multifactor ETF|
|Micro-Cap Ishares ETF|
|Russell 2000 Growth Ishares ETF|
|Defiance Nasdaq Junior Biotechnology ETF|